Madrigal Pharmaceuticals, Inc.
(MDGL - NASDAQ)
523,42 USD
📋 Profilo Aziendale

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases.

|